Cooper Companies Stock Drops Over 13% After Disappointing Earnings Report
On September 10, 2026, shares of Cooper Companies (NASDAQ: COO) fell by approximately 13.9%, driven primarily by a disappointing earnings report and weak guidance for the fourth quarter. While the company beat adjusted EPS estimates in Q3 with $1.15 per share, it missed revenue expectations at $1.07 billion. The more significant issue was its forecast of $1.05 to $1.09 per share for Q4, which fell below Wall Street's estimate of $1.19. Additionally, Cooper Companies announced that after a strategic review, the board decided not to sell off CooperSurgical—a move investors had anticipated and priced into the stock. This decision removed an expected catalyst for growth or value realization, further disappointing shareholders.
Tickers: $COO
Topics: financial performance medical devices stock price drop